technetium tc 99m sestamibi has been researched along with wk-x-34 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breitbach, K; Jekerle, V; Klinkhammer, W; Piquette-Miller, M; Reilly, RM; Scollard, DA; Wiese, M | 1 |
1 other study(ies) available for technetium tc 99m sestamibi and wk-x-34
| Article | Year |
|---|---|
In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques.
Topics: Antineoplastic Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Cell Line, Tumor; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flow Cytometry; Fluorescence; Gene Expression Regulation, Neoplastic; Humans; Mitoxantrone; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Ovarian Neoplasms; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors; Tissue Distribution; Transplantation, Heterologous; Up-Regulation | 2006 |